Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: BIOFACTURA INC
Awarding agency: Department of Defense / Defense Threat Reduction Agency
Funding agency: Department of Defense / Defense Threat Reduction Agency
Period of performance: 2020-06-15 to 2022-09-14
Current total value of award: $999398.93
Description: SBIR PHASE II MANUFACTURE OF AN ANTIBODY-BASED THERAPY AGAINST MARBURG VIRUS.